Bryn Mawr Capital Management LLC Sells 27,339 Shares of Agilent Technologies, Inc. (NYSE:A)

Bryn Mawr Capital Management LLC reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 80.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,649 shares of the medical research company’s stock after selling 27,339 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Agilent Technologies were worth $893,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Massachusetts Financial Services Co. MA lifted its position in shares of Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after purchasing an additional 525,214 shares in the last quarter. FMR LLC increased its stake in Agilent Technologies by 62.2% in the 3rd quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock valued at $191,193,000 after buying an additional 493,947 shares during the last quarter. Worldquant Millennium Advisors LLC bought a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $49,449,000. Van ECK Associates Corp boosted its stake in shares of Agilent Technologies by 8.7% in the 4th quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock worth $434,625,000 after buying an additional 258,358 shares during the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Agilent Technologies by 63.3% in the third quarter. Jennison Associates LLC now owns 586,439 shares of the medical research company’s stock valued at $87,075,000 after acquiring an additional 227,431 shares in the last quarter.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This represents a 4.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Agilent Technologies Trading Down 0.3 %

NYSE:A opened at $136.74 on Friday. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The stock’s fifty day moving average price is $141.04 and its two-hundred day moving average price is $139.28. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The company has a market cap of $39.01 billion, a P/E ratio of 30.94, a P/E/G ratio of 3.66 and a beta of 1.07.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the firm posted $1.38 EPS. The firm’s quarterly revenue was up .8% on a year-over-year basis. As a group, analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.73%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.40%.

Analyst Ratings Changes

A has been the topic of a number of recent analyst reports. Bank of America dropped their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $135.00 to $145.00 in a report on Monday, February 10th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Sanford C. Bernstein lowered their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday, November 26th. Finally, Citigroup increased their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $144.38.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.